This case report demonstrates the effectiveness of rituximab as a first-line and maintenance treatment for this rare antineutrophil cytoplasmic antibody-associated vasculitis.
This case report demonstrates the effectiveness of rituximab as a first-line and maintenance treatment for this rare antineutrophil cytoplasmic antibody-associated vasculitis.
This case report demonstrates...